Summary by Futu AI
Drugstore Co., Ltd. (“YSB”) announced on February 28, 2024 that its subsidiary Guangzhou Pharmaceutical Information Technology Co., Ltd., entered into an investment agreement with Shanghai Rui Yu'an Health Technology Co., Ltd. and its shareholders. Under the agreement, Guangzhou Pharmaceutical will invest RMB 10.0 million to hold 13% equity interest in Rui Select Health, which will become an important business partner of YSB Group upon completion of the investment. Intellectual Health is a third-party service company focused on health consumer commercial insurance, whose business helps build a complete healthcare coverage system. Pharmacists said the investment will help provide more secure day-to-day patient purchasing services, expand downstream customer demand, and empower upstream industries to form a more comprehensive ecosystem in line with the company's long-term development plans through accurate terminal consumer data. The investment does not constitute a publicable or connected transaction and is therefore a voluntary announcement.